Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Chinese Patent Office
Moodys
Harvard Business School
Argus Health

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,821,114

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,821,114
Title:Compartmentalized method of nucleic acid delivery and compositions and uses thereof
Abstract: Provided herein is a method of delivering nucleic acid molecules to a compartmentalized tissue or organ of a subject. Also provided herein are uses and processes for delivering a nucleic acid molecule to the parenchyma of a compartmentalized tissue or organ. The methods and uses can be used in the treatment of diseases and conditions and in industrial, agricultural and veterinary applications. Also provided herein are compositions containing an adenovirus or adeno-associated virus or other recombinant virus formulated for administration to the parenchyma of a tissue or organ.
Inventor(s): Cabrera Aquino; Jose Gustavo (Mexico City, MX), Segura Pacheco; Blanca Angelica (Mexico City, MX)
Assignee: Global Bio Therapeutics, Inc. (San Diego, CA)
Application Number:13/815,206
Patent Claims:see list of patent claims

Details for Patent 9,821,114

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biomarin ALDURAZYME laronidase VIAL 125058 001 2003-04-30 ➤ Sign Up Global Bio Therapeutics, Inc. (San Diego, CA) 2032-02-07 RX search
Biomarin NAGLAZYME galsulfase INJECTABLE; INJECTION 125117 001 2005-05-31 ➤ Sign Up Global Bio Therapeutics, Inc. (San Diego, CA) 2032-02-07 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Merck
Julphar
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.